Ibrutinib-Plus-Rituximab Combo Shows High Response Rates in MCL

(MedPage Today) -- At December's American Society of Hematology virtual meeting, a phase II trial was presented on ibrutinib and rituximab for older patients with newly diagnosed mantle cell lymphoma.
In this exclusive MedPage Today video, study...